Evaluation of the safety of tranexamic acid use in pediatric patients undergoing spinal fusion surgery: a retrospective comparative cohort study

BACKGROUND: Pediatric spinal fusion may be associated with significant intraoperative blood loss, leading to complications from transfusion, hypoperfusion and coagulopathy. One emerging strategy to mediate these risks is by utilization of the anti-fibrinolytic agent tranexamic acid (TXA). However, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivasyk, Iryna, Chatterjee, Abhinaba, Jordan, Catherine, Geiselmann, Matthew T., Chang, Peter S., Kamel, Hooman, Khormaee, Sariah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264589/
https://www.ncbi.nlm.nih.gov/pubmed/35804327
http://dx.doi.org/10.1186/s12891-022-05604-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264589/
https://www.ncbi.nlm.nih.gov/pubmed/35804327
http://dx.doi.org/10.1186/s12891-022-05604-2

Ejemplares similares